AIFAIM
ABBV icon

American Institute for Advanced Investment Management’s AbbVie ABBV Stock Holding History

American Institute for Advanced Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Sell
7,204
-455
-6% -$97.9K 1.05% 25
2026
Q1 		$1.67M Hold
7,659
– – 1.08% 23
2025
Q4 		$1.74M Sell
7,659
-25
-0.3% -$5.7K 1.12% 22
2025
Q3 		$1.78M Sell
7,684
-250
-3% -$50.9K 1.17% 24
2025
Q2 		$1.47M Sell
7,934
-10
-0.1% -$1.86K 1.04% 25
2025
Q1 		$1.66M Buy
7,944
+215
+3% +$41.8K 1.27% 18
2024
Q4 		$1.37M Sell
7,729
-783
-9% -$144K 1.02% 28
2024
Q3 		$1.68M Buy
8,512
+101
+1% +$18.9K 1.2% 18
2024
Q2 		$1.44M Sell
8,411
-27
-0.3% -$4.47K 1.1% 21
2024
Q1 		$1.54M Buy
8,438
+486
+6% +$83.8K 1.21% 18
2023
Q4 		$1.23M Sell
7,952
-447
-5% -$65.2K 1.09% 22
2023
Q3 		$1.28M Sell
8,399
-271
-3% -$39.8K 1.18% 22
2023
Q2 		$1.17M Buy
8,670
+726
+9% +$106K 1.02% 26
2023
Q1 		$1.17M Sell
7,944
-1,549
-16% -$237K 1.25% 19
2022
Q4 		$1.53M Buy
9,493
+421
+5% +$64.6K 1.4% 18
2022
Q3 		$1.22M Buy
9,072
+3,235
+55% +$464K 1.14% 27
2022
Q2 		$894K Sell
5,837
-230
-4% -$35.1K 0.78% 41
2022
Q1 		$984K Sell
6,067
-40
-0.7% -$5.81K 0.71% 45
2021
Q4 		$827K Buy
6,107
+45
+0.7% +$5.32K 0.56% 51
2021
Q3 		$654K Hold
6,062
– – 0.46% 61
2021
Q2 		$683K Sell
6,062
-342
-5% -$38.5K 0.48% 58
2021
Q1 		$693K Sell
6,404
-10
-0.2% -$1.07K 0.53% 55
2020
Q4 		$687K Hold
6,414
– – 0.55% 53
2020
Q3 		$562K Sell
6,414
-125
-2% -$11.8K 0.5% 53
2020
Q2 		$642K Buy
6,539
+3,180
+95% +$280K 0.61% 52
2020
Q1 		$256K Hold
3,359
– – 0.28% 76
2019
Q4 		$297K Buy
+3,359
New +$279K 0.29% 76

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

American Institute for Advanced Investment Management's ABBV Position: Q2 2026 in Review

American Institute for Advanced Investment Management reduced its AbbVie (ABBV) stake by 5.9% in Q2 2026, selling an estimated $97.9K and leaving 7,204 shares worth $1.81M. The position accounts for 1.05% of the portfolio, ranked #25.

American Institute for Advanced Investment Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 3,019 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • American Institute for Advanced Investment Management held 7,204 shares of AbbVie worth $1.81M as of Q2 2026.
  • American Institute for Advanced Investment Management sold 455 AbbVie shares in Q2 2026, an estimated $97.9K.
  • AbbVie made up 1.05% of American Institute for Advanced Investment Management's portfolio in Q2 2026, its #25 holding.
  • American Institute for Advanced Investment Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 3,019 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on American Institute for Advanced Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.